Standard

Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II. / Васильев, И.В.; Горобец, Е.А.; Арчакова, Л.И.; Маменко, И.С.; Зайцев, И.А.; Яблонский, П.К.

в: Медицинский альянс, № 2, 2019, стр. 65-69.

Результаты исследований: Научные публикации в периодических изданиях › статья

Harvard

Васильев, ИВ, Горобец, ЕА, Арчакова, ЛИ, Маменко, ИС, Зайцев, ИА & Яблонский, ПК 2019, 'Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II.', Медицинский альянс, № 2, стр. 65-69. <http://elibrary.ru/item.asp?id=38073051>

APA

Васильев, И. В., Горобец, Е. А., Арчакова, Л. И., Маменко, И. С., Зайцев, И. А., & Яблонский, П. К. (2019). Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II. Медицинский альянс, (2), 65-69. http://elibrary.ru/item.asp?id=38073051

Vancouver

Васильев ИВ, Горобец ЕА, Арчакова ЛИ, Маменко ИС, Зайцев ИА, Яблонский ПК. Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II. Медицинский альянс. 2019;(2):65-69.

Author

Васильев, И.В. ; Горобец, Е.А. ; Арчакова, Л.И. ; Маменко, И.С. ; Зайцев, И.А. ; Яблонский, П.К. / Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II. в: Медицинский альянс. 2019 ; № 2. стр. 65-69.

BibTeX

@article{52fe05bc644445c1b15a1ef1975e1710,
title = "Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II.",
abstract = "Summary Despite the 10 years of history of EBUS and more then 50 years of TBLB, the evidence of the usefulness of their combination or sequence are not enough till now. The aim: to compare the diagnostic efficacy of TBLB, EBUS and their combination in verification of sarcoidosis II. Design: a prospective non-randomized trial with conse­cutively enrolled patients from January 2018 till December 2018. Inclusion's criteria: Patients older than 18 years with the revealed pathology in the chest CT: suspicion of sarcoidosis II (coexistence of pulmonary dissemination and mediastinal lymphadenopathy). Exclusion's criteria: previously confirmed the diagnosis without the invasive procedure, contraindications to bronchoscopy and general anesthesia or inability to consent. Material and methods: 100 patients were enrolled in the trial. Patients were divided into 3 groups: group 1 (TBLB) - 50 patients, group 2 (EBUS) - 35 patients, group 3 (TBLB and EBUS) - 15 patients. TBLB and EBUS-TBNA were performed by the experienced",
keywords = "EBUS-TBNA, lung dissemination, sarcoidosis, TBBL, диссеминированный процесс, саркоидоз, ультразвуковая бронхоскопия, чрезбронхиальная биопсия легкого, EBUS-TBNA, lung dissemination, sarcoidosis, TBBL, диссеминированный процесс, саркоидоз, ультразвуковая бронхоскопия, чрезбронхиальная биопсия легкого",
author = "И.В. Васильев and Е.А. Горобец and Л.И. Арчакова and И.С. Маменко and И.А. Зайцев and П.К. Яблонский",
year = "2019",
language = "English",
pages = "65--69",
journal = "Медицинский альянс",
issn = "2307-6348",
publisher = "Национальная Ассоциация Фтизиатров",
number = "2",

}

RIS

TY - JOUR

T1 - Comparative study for diagnostic yield of TBLB and EBUS and their combination in verification of sarcoidosis II.

AU - Васильев, И.В.

AU - Горобец, Е.А.

AU - Арчакова, Л.И.

AU - Маменко, И.С.

AU - Зайцев, И.А.

AU - Яблонский, П.К.

PY - 2019

Y1 - 2019

N2 - Summary Despite the 10 years of history of EBUS and more then 50 years of TBLB, the evidence of the usefulness of their combination or sequence are not enough till now. The aim: to compare the diagnostic efficacy of TBLB, EBUS and their combination in verification of sarcoidosis II. Design: a prospective non-randomized trial with conse­cutively enrolled patients from January 2018 till December 2018. Inclusion's criteria: Patients older than 18 years with the revealed pathology in the chest CT: suspicion of sarcoidosis II (coexistence of pulmonary dissemination and mediastinal lymphadenopathy). Exclusion's criteria: previously confirmed the diagnosis without the invasive procedure, contraindications to bronchoscopy and general anesthesia or inability to consent. Material and methods: 100 patients were enrolled in the trial. Patients were divided into 3 groups: group 1 (TBLB) - 50 patients, group 2 (EBUS) - 35 patients, group 3 (TBLB and EBUS) - 15 patients. TBLB and EBUS-TBNA were performed by the experienced

AB - Summary Despite the 10 years of history of EBUS and more then 50 years of TBLB, the evidence of the usefulness of their combination or sequence are not enough till now. The aim: to compare the diagnostic efficacy of TBLB, EBUS and their combination in verification of sarcoidosis II. Design: a prospective non-randomized trial with conse­cutively enrolled patients from January 2018 till December 2018. Inclusion's criteria: Patients older than 18 years with the revealed pathology in the chest CT: suspicion of sarcoidosis II (coexistence of pulmonary dissemination and mediastinal lymphadenopathy). Exclusion's criteria: previously confirmed the diagnosis without the invasive procedure, contraindications to bronchoscopy and general anesthesia or inability to consent. Material and methods: 100 patients were enrolled in the trial. Patients were divided into 3 groups: group 1 (TBLB) - 50 patients, group 2 (EBUS) - 35 patients, group 3 (TBLB and EBUS) - 15 patients. TBLB and EBUS-TBNA were performed by the experienced

KW - EBUS-TBNA

KW - lung dissemination

KW - sarcoidosis

KW - TBBL

KW - диссеминированный процесс

KW - саркоидоз

KW - ультразвуковая бронхоскопия

KW - чрезбронхиальная биопсия легкого

KW - EBUS-TBNA

KW - lung dissemination

KW - sarcoidosis

KW - TBBL

KW - диссеминированный процесс

KW - саркоидоз

KW - ультразвуковая бронхоскопия

KW - чрезбронхиальная биопсия легкого

M3 - Article

SP - 65

EP - 69

JO - Медицинский альянс

JF - Медицинский альянс

SN - 2307-6348

IS - 2

ER -

ID: 78579992